4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001628280-26-001895
Chief Executive Officer sold 26,472 shares at an average $1.77 ($46,954)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| OConnell Daniel Joseph Chief Executive Officer | 2026-01-08 | Sale | −8,143 | $1.82 | $14,815 | 611,839 | D |
| OConnell Daniel Joseph Chief Executive Officer | 2026-01-09 | Sale | −12,941 | $1.76 | $22,832 | 598,898 | D |
| OConnell Daniel Joseph Chief Executive Officer | 2026-01-12 | Sale | −5,388 | $1.73 | $9,307 | 593,510 | D |
| Open-market sales · 26,472 sh · avg $1.77 · $46,954 | |||||||
Loading xslF345X05/wk-form4_1768261820.xml…